Low density lipoprotein is the major carrier of cholesterol in the blood.

Bad cholesterol or low-density lipoprotein is harmful because it can cause atheroma.

Low-density lipoprotein, or LDL cholesterol, and triglycerides were increased, while protective high-density lipoprotein, or HDL cholesterol, were decreased.

A soluble derivative of low-density lipoprotein receptor related protein-1 (sLRP-1) binds directly to Alzheimer's amyloid-β peptide (Aβ).

Consuming too many saturated and trans fats increases your low-density lipoprotein (LDL), known as “bad” cholesterol.

If your blood contains too much LDL cholesterol (low-density lipoprotein cholesterol), it is called high cholesterol.

Disclosed is a composition for reducing the level of glucose, a malondialdehyde-modified LDL, homocysteine and/or a C-reactive protein in the blood.

Brain endothelial low-density lipoprotein receptor related protein-1 (LRP-1) mediates vascular clearance of Alzheimer's amyloid-β peptide (Aβ) from the brain.

If your blood contains too much LDL cholesterol (cholesterol carried by low-density lipoprotein), it’s known as high cholesterol.

Plasma oxidized LDL (low-density lipoprotein), a marker of oxidative stress, also was lower after MitoQ versus placebo.

Scientists report that quercetin may help prevent the oxidation of low-density lipoprotein (LDL), which can provide important atherosclerosis.

Elevated low-density lipoprotein (LDL, or “bad”) cholesterol is a clearly established risk factor for the development of cardiovascular disease (CVD).

Scientists report that quercetin may help prevent the oxidation of low-density lipoprotein (LDL), which can provide important atherosclerosis.

Pine nut oil contains pinolenic acid, which affects the low-density lipoprotein (LDL) receptor activity of human hepatoma HepG2 cells.

low-density lipoprotein (LDL): Also called "bad cholesterol," LDL builds up in the blood vessel walls, damaging and narrowing them.